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Background: Irreversible electroporation (IRE) is a non-thermal injury tissue ablation technique that uses electrical pulses
to cause cell death. IRE damages the endothelial cells of blood vessels; however these cells re-grow, and thus IRE does
not result in permanent damage to blood vessels. We report the novel use of IRE for ablation of microscopically positive
margins after resection of colorectal liver metastases (CRLM) impinging on hepatic veins.
Case presentation: A 68-year-old female was found to have colon cancer and synchronous bilateral unresectable
liver metastases. Chemotherapy with FOLFOX and cetuximab was initiated, with subsequent conversion to resectability
of the CRLM. The patient underwent colectomy followed by right liver posterior sectionectomy with wedge resection
of segment 5. Resection of tumor impinging on the left and middle hepatic veins would have required left
hepatectomy, with insufficient remnant liver volume. The CRLM were meticulously dissected off the hepatic
veins leaving a microscopically positive margin, and IRE was then used for margin ablation, leaving intact hepatic veins
and venous blood flow. The patient is alive and without recurrent disease now 30 months after resection. Herein we
review the IRE technology and its use in ablation of liver metastases.
Conclusions: Use of IRE margin ablation for microscopically-positive CRLM resection may lead to long-term patient
survival; further prospective randomized trials are needed to confirm this finding.
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MetastasectomyBackground
Resection of colorectal liver metastases (CRLM) has
been well described, with reports of five-year survival up
to 58% after complete resection of disease [1]. The over-
arching goals of liver resection for CRLM are to obtain
tumor-free margins and a functioning liver remnant with
intact portal venous and arterial inflow, venous outflow,
and biliary-enteric drainage [2,3]. An operation should
be undertaken with the intent of a margin-negative re-
section, as patients with a positive resection margin have* Correspondence: gsingh@coh.org
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article, unless otherwise stated.significantly increased risk for local recurrence as well as
significantly decreased overall survival compared with
margin-negative patients [4]. The extent of liver resec-
tion, and the success of a margin-negative resection,
may be limited by concomitant intrinsic liver disease,
chemotherapy-induced liver damage, and the anatomic
location of the metastases. Tumors adjacent to major
hepatic blood vessels may pose a challenge to resection
if, in taking the tumor and associated blood vessel, an
inadequate amount of liver is left behind to support hep-
atic function post-operatively.
In the past, tumor adjacent to major hepatic blood
vessels (e.g., hepatic vein, portal vein) has been a relative
contraindication to surgery if tumor-free margins areCentral. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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remnant; however, with the use of irreversible electro-
poration (IRE), a relatively new ablation technique, in
combination with hepatic resection, tumors may be
safely treated while preserving the hepatic vasculature.
Irreversible electroporation is a non-thermal injury tis-
sue ablation technique that uses electrical pulses of short
duration to permanently create defects in cell mem-
branes leading to irreversible permeabilization and ul-
timately cell death [5]. Vessels adjacent to the zone of
ablation do not cause a heat sink effect, as may be seen
in radiofrequency or microwave ablation. Furthermore,
IRE has a very low incidence of collateral damage to ad-
jacent structures, making it possible to ablate tumors ad-
jacent to major hepatic vessels [6]. In this report we
describe a novel technique of hepatic resection followed
by margin ablation using IRE as a treatment for CRLM
near major vascular structures, resulting in long-term
and durable patient survival.
Case presentation
The patient is a 68-year-old female who sought medical
care at an outside facility after passing bright red blood
per rectum. Laboratory evaluation demonstrated anemia.
The patient was otherwise without other complaints at
the time of presentation, denying nausea, vomiting,
change in bowel habits, jaundice, decreased appetite and
early satiety. The patient underwent a diagnostic colon-
oscopy which demonstrated a friable ulcerated circum-
ferential mass in the mid-transverse colon, causing 50%
occlusion of the lumen; biopsy of the mass demonstrated
colonic adenocarcinoma that was KRAS wild-type. The
patient underwent full staging with CT scans of theFigure 1 On initial presentation the patient was found to have multiple hypo
and the burden of disease was deemed not resectable.chest, abdomen, and pelvis, which confirmed the mass
in the mid-transverse colon, as well as multiple large
hypodense hepatic lesions located in segments 2, 4A, 5,
6, 7 (Figure 1). This workup was performed at the out-
side facility, including the performance of CT-guided
liver biopsy which confirmed metastatic adenocarcin-
oma. Liver function tests and coagulation parameters
were all normal at the time of presentation.
The patient was referred to medical oncology and began
chemotherapy with fluorouracil, oxaliplatin, and leucov-
orin (FOLFOX) with cetuximab. The patient underwent
seven cycles of chemotherapy over three months and was
subsequently referred to our institution for evaluation.
Upon review of restaging CT and PET/CT scans ob-
tained during and after chemotherapy, the patient was
noted to have decrease in size of both the primary co-
lonic lesion as well as the liver metastases, without evi-
dence of new foci of metastatic disease (Figure 2). Both
the primary colon cancer and hepatic metastases were
deemed to be resectable, with the proposed surgical plan
being an extended right colectomy with a right posterior
sectionectomy and wedge resections of the segment 2,
4A, and 5 lesions.
The patient was taken to the operating room and under-
went a right colectomy with ileocolic anastomosis without
incident and attention was then turned to the liver. Intra-
operative hepatic ultrasound revealed three multi-lobulated
lesions within segments 6 and 7, a small segment 5 lesion,
as well as a segment 2 and 4A lesion between the middle
and left hepatic veins. The metastases were resectable, and
the liver, while appearing to have some damage as a result
of chemotherapy, was felt to have adequate volume for a
functioning liver remnant.dense hepatic metastases in segments 2 and 4A as well as segments 5-7
Figure 2 Appearance of hepatic metastases in segments 2 and 4A (top) and segments 5-7 (bottom) after treatment with FOLFOX chemotherapy
with cetuximab. The disease burden has decreased and the patient has been converted to resectable status.
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fashion using electrocautery and hemostatic clips. This
was a margin-negative resection despite its close prox-
imity to the portal venous system. A right posterior sec-
tionectomy was performed removing segments 6 and 7,
along with a cholecystectomy. The right hepatic vein as
well as the right posterior portal pedicles, and a few ter-
tiary branches of the right anterior portal vein, were seen
entering the tumor and were taken. Intraoperative
pathologic assessment of this specimen reported nega-
tive margins (3-4 mm).
Attention was then turned to the lesions in segments 2
and 4A. A formal left hepatectomy would have allowed
for a margin-negative resection; however the end result
would have resulted in less than 30% liver remnant in an
already chemotherapy-treated liver. Based on pre-operative volumetric data, the right anterior section con-
stituted approximately 30% future liver remnant (Figure 3),
and following a segment 5 wedge resection this volume
was further reduced. It was decided to dissect out the
tumor, lifting it off of the underlying hepatic veins
(Figure 4). No attempt was made to obtain negative
margins because of extreme proximity to the hepatic
veins, and thus the tumor was meticulously dissected
off of the veins with the understanding that micro-
scopic disease would be left on the vessels. Following
completion of tumor excision, normal flow was seen in
the left and middle hepatic veins on ultrasound.
Given the microscopic positive margins at the middle
and left hepatic veins, we decided to ablate the vein mar-
gins using IRE (NanoKnife System, AngioDynamics,
Latham, NY). The resection bed of segments 2 and 4A
Figure 3 Volumetrics of highlighted segments 5/8 demonstrate a future liver remnant of approximately 30%.
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1.5 cm apart and 1.5 cm deep into the hepatic paren-
chyma that remained just adjacent to the hepatic veins.
The needle pairs were placed parallel to the veins and
the covered with a free flap of omental fat that had
been harvested to add extra tissue through which the
electrical current would travel such that the positive
surfaces of the veins would be treated. Treatments wereFigure 4 Intra-operative photograph after resection of tumor from segmen
was carefully dissected off of the middle hepatic (white arrow) and left hepperformed with settings of 3000 V using 100 microsec-
ond pulses for a total of 90 pulses between each needle
pair. A total of seven overlapping ablations were per-
formed across the entire raw surface area. The omental
fat pad was discarded, and following the completion of
IRE, adequate flow was again confirmed through the
left and middle hepatic veins without evidence of
thrombosis. The patient tolerated the procedure wellts 2 and 4A with likely microscopically positive margin after tumor
atic veins (black arrow).
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tient was discharged home on post-operative day 9 in
good condition with normal liver function.
Pathology of the resected right colon demonstrated
well-to-moderately differentiated adenocarcinoma invad-
ing through the muscularis propria to the subserosal tis-
sue. All margins were negative and 0/43 regional lymph
nodes were positive for carcinoma. The final pathology
of the resected right posterior section demonstrated
three masses, the largest of which was 3 cm, and nega-
tive margins. Pathologic result of the segment 2/4A re-
section specimen demonstrated a 3.6 cm mass with
viable carcinoma present at the inked margin of resec-
tion, as had been anticipated, and which had been ab-
lated by IRE. The patient now continues to be under
active surveillance and has shown no demonstrable evi-
dence of recurrence along the ablated margin 30 months
after the operation (Figure 5).
Discussion
Resection of CRLM has been widely described, and sur-
vival has been reported to range anywhere from 25-70%
following surgical resection [2,7,8]. Previously-held trad-
itional resection principles, such as obtaining 1 cm mar-
gins [9] have changed, and eligibility for curative resection
now depends on the ability to obtain negative margins on
all lesions with an adequate liver remnant [3,10].
Irreversible electroporation is a non-thermal ablation
technique whereby electrical pulses delivered to tissue
between two or more probes cause the creation of per-
manent cell membrane nanopores, with subsequent
breakdown of cell membranes and death by apoptosisFigure 5 Appearance of the liver remnant 18 months after resection; th
in segments 2/4A (arrow) or in the remainder of the liver, the middle an
undergone hypertrophy.[5]. Notably, after IRE the extracellular matrix is left in-
tact, which allows for the preservation of blood vessels
and bile ducts [11]; this quality makes IRE an attractive
adjunctive treatment in the management of tumors abut-
ting major vascular and biliary structures by limiting col-
lateral damage done to these critical structures during
ablation. In addition, thermal ablation modalities that
depend on heating the tissue to be ablated to 60°C for
cell death may fail to reach the target temperature in
areas adjacent to large vessels due to a heat sink effect
with risk for incomplete ablation and recurrence [6]; this
is not the case with the use of IRE near large vessels.
While response rates and long-term survival data from
large prospective clinical trials using IRE are still awaited,
multiple previous case report series have detailed the use
of IRE for the treatment of both metastatic and primary
carcinomas of the liver (Table 1), and the procedure has
been found to be safe and efficacious. Cannon and col-
leagues prospectively analyzed outcomes of 44 patients
with hepatic tumors (20 patients with CRLM, 14 hepato-
cellular carcinoma [HCC], and 10 other metastasis) who
underwent 48 IRE procedures [12]. In all 48 of the IRE
procedures the tumors were located in close proximity to
major vascular or biliary structures or to adjacent organs.
Nine adverse events occurred in five patients, all of which
resolved within 30 days, and no deaths, biliary stricture, or
portal vein thromboses were reported. Local recurrence
free survival was reported at 3, 6, and 12 months to be
97.4%, 94.6%, and 59.5%, respectively, and was 100%,
100%, and 98% for lesions less than 3 cm. The authors
concluded that IRE is safe for use in proximity to vital
structures. Similarly, Kingham et al. reported their seriesere is no evidence of recurrent disease at the site of margin ablation
d left hepatic veins are patent, and the liver remnant has
Table 1 Selected reports of irreversible electroporation (IRE) in the treatment of hepatic metastases




Complications Follow-up duration Recurrence-free survival
Cannon et al. [12] 2013 44 48 9 NR 94.6% 6-mo. 59.5% 12-mo.
Kingham et al. [13] 2012 28 65 2 Median 6 mo NR
Cheung et al. [14] 2013 11 18 11 Mean 18 mo (14-24) 18 ± 4 mo.
NR = not recorded.
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amenable to thermal ablation due to tumor location [13].
Twenty-eight patients underwent 65 IRE treatments, and
the median tumor size was 1 cm (range 0.5-5 cm). The au-
thors reported one intra-operative arrhythmia and one
post-operative portal vein thrombosis, with an overall
morbidity of 3% and no mortalities. With a median
follow-up time of six months, one tumor was found to
have persistent disease, and three tumors had undergone
local recurrence. The authors concluded that IRE is safe
in the treatment of perivascular hepatic tumors. Cheung
and colleagues reported on eleven patients with HCC
who underwent treatment of 18 HCC lesions with IRE
with a median follow-up time of 18 months [14]. Of the
18 tumors, 72% were ablated, with 93% success for tu-
mors ≤3 cm. No serious complications were reported,
although four patients developed transient urinary re-
tention and seven developed post-procedure pain. The
authors reported a local recurrence-free period of 18 ±
4 months and concluded that IRE is not only feasible
but safe for the ablation of HCC.
The role of IRE in the spectrum of treatment for tu-
mors metastatic to the liver currently is in evolution and
will continue to be refined with time. Currently it ap-
pears that the role of IRE will be for local ablation of
unresectable masses adjacent to major vascular or biliary
structures or for margin ablation to facilitate extended
resections, and at the present time IRE will not replace
the need for systemic neoadjuvant or adjuvant chemo-
therapy. It is also currently unclear if disease requiring
the use of both liver resection and ablation with IRE in-
dicates more aggressive disease biology, although it is
certain that patients with positive surgical margins after
resection of CRLM will have worse biology of disease
with decreased outcomes and survival [15].
Herein we describe the use of IRE to treat resection
margins when the likelihood of positive margins is sig-
nificant, and the use of IRE in this fashion allows com-
pletion of major liver resections in one stage as opposed
to the use of a two-stage operation with portal vein
embolization. In our case the multiple areas of meta-
static disease and disease abutting major vascular struc-
tures were impediments to performing a traditional
metastasectomy with negative margins. Our resection
left microscopic disease behind at the margin abutting
the vasculature; however the addition of IRE allowed forablation of this tissue and destruction of the remaining
microscopic disease, thus allowing for complete eradica-
tion of the patient’s metastatic disease with preserved
hepatic venous flow, an adequately functioning liver
remnant, and long-term survival benefit.
Conclusion
Large prospective trials studying the use of IRE for abla-
tion of unresectable hepatic disease are ongoing; how-
ever long-term outcomes data on the use of IRE are
currently lacking. We present a novel technique that
combines liver resection with ablation of surgical mar-
gins using IRE with the intent to eradicate all disease in
an area where use of standard microwave or radiofre-
quency ablation would have resulted in damage to the
hepatic veins and a potentially disastrous patient out-
come. We believe this technique is especially useful in
those patients with poor hepatic reserve, tumors abut-
ting major vasculature or bile ducts, and in those pa-
tients with large tumor burdens, and may offer patients
the possibility of long-term disease-free survival.
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